Aclaris Therapeutics, Inc. (ACRS)

3.205 -0.04 (-1.08%) USD  |  NASDAQ  |  Feb 23, 14:13
More

Aclaris Therapeutics Net Common Equity Issued (Purchased) (Quarterly)

Net Common Equity Issued (Purchased) (Quarterly) Chart

View Net Common Equity Issued (Purchased) (Quarterly) for ACRS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Quarterly) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Quarterly) Benchmarks

View Net Common Equity Issued (Purchased) (Quarterly) Benchmarks
Start Trial
Oramed Pharmaceuticals, Inc. Upgrade
PMV Pharmaceuticals, Inc. Upgrade
Atea Pharmaceuticals, Inc. Upgrade
Instil Bio, Inc. Upgrade
Definium Therapeutics, Inc. Upgrade